Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development | Zendy

Peng Xu | Zendy; Safder S. Ganaie | Zendy; Xiaomei Wang | Zendy; Zekun Wang | Zendy; Steve Kleiboeker | Zendy; Nancy C. Horton | Zendy; Richard F. Heier | Zendy; Marvin J. Meyers | Zendy; John E. Tavis | Zendy; Jianming Qiu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development

Author(s) -

Peng Xu,

Safder S. Ganaie,

Xiaomei Wang,

Zekun Wang,

Steve Kleiboeker,

Nancy C. Horton,

Richard F. Heier,

Marvin J. Meyers,

John E. Tavis,

Jianming Qiu

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01879-18

Subject(s) - biology , parvovirus , dna replication , microbiology and biotechnology , dna , in vitro , viral replication , virology , virus , biochemistry

Human parvovirus B19 (B19V), a member of the genusErythroparvovirus of the familyParvoviridae , is a small nonenveloped virus that has a single-stranded DNA (ssDNA) genome of 5.6 kb with two inverted terminal repeats (ITRs). B19V infection often results in severe hematological disorders and fetal death in humans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research